KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Depreciation & Amortization - Total (2016 - 2025)

Evolent Health (EVH) has 11 years of Depreciation & Amortization - Total data on record, last reported at $6.3 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization - Total fell 14.86% year-over-year to $6.3 million; the TTM value through Dec 2025 reached $26.3 million, down 13.2%, while the annual FY2025 figure was $26.3 million, 13.2% down from the prior year.
  • Depreciation & Amortization - Total reached $6.3 million in Q4 2025 per EVH's latest filing, roughly flat from $6.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $8.9 million in Q4 2022 and bottomed at $6.3 million in Q3 2025.
  • Average Depreciation & Amortization - Total over 5 years is $7.6 million, with a median of $7.6 million recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization - Total: increased 10.39% in 2023, then dropped 18.99% in 2025.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $7.4 million in 2021, then rose by 20.27% to $8.9 million in 2022, then dropped by 14.61% to $7.6 million in 2023, then dropped by 2.63% to $7.4 million in 2024, then decreased by 14.86% to $6.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization - Total were $6.3 million in Q4 2025, $6.3 million in Q3 2025, and $6.4 million in Q2 2025.